SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Divi's Laboratories starts commercial operations of Unit III greenfield project at Andhra Pradesh

02 Jan 2025 Evaluate

Divi's Laboratories has commenced commercial operations from a part of the Phase I of Unit III greenfield project at Kakinada, Andhra Pradesh from January 01, 2025. It may be recalled that the phase I of the Unit III greenfield project of the Company at Kakinada, Andhra Pradesh is being implemented on 200 acres of 500 acres Unit III site, with an estimated investment between Rs 1,200 crore to Rs 1,500 crore.

Divi's Laboratories is one of the leading pharmaceutical companies in the world.


Divis Lab Share Price

6228.95 -68.55 (-1.09%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×